HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, K. F. Articles by Guerraty, A. J. Search for Related Content PubMed PubMed Citation Articles by Lee, K. F. Articles by Guerraty, A. J.

The Annals of Thoracic Surgery, Vol 52, 211-217, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Cardiac transplantation with corticosteroid-free immunosuppression: long-term results

KF Lee, JD Pierce, ML Hess, AK Hastillo, AS Wechsler and AJ Guerraty
Department of Surgery, Medical College of Virginia-Virginia Commonwealth University, Richmond 23298.

To assess the long-term safety of an immunosuppressive regimen without corticosteroids, we retrospectively evaluated 42 long-term (greater than 1 year) survivors of orthotopic cardiac transplantation. We determined the incidence of (1) conversion of the immunosuppressive regimen from cyclosporine and azathioprine alone (group I) to cyclosporine, azathioprine, and prednisone (group II), (2) late acute graft rejection (defined as occurring at greater than 1 postoperative year), and (3) major postoperative complications related to corticosteroids. Of the 42 patients who were started on cyclosporine and azathioprine, 48% remained in group I, and 52% converted to group II. Forty-five percent of group II patients were able to taper and discontinue prednisone in 15.6 +/- 2.2 months. Among the patients on long-term corticosteroid-free immunosuppression, the incidence of late rejection was 2.1% per endomyocardial biopsy. The incidence of late infectious episodes was not significantly different between the two groups of patients, although diabetes mellitus and hypercholesterolemia were more prevalent in group II than in group I. These data suggest that cardiac transplant recipients who chronically remain on corticosteroid-free immunosuppression represent a select group of patients with an acceptably low risk of late graft rejection and associated reduction of potential risk factors of accelerated coronary artery disease.

This article has been cited by other articles:

				D. H. Rosenbaum, B. C. Adams, J. D. Mitchell, M. E. Jessen, M. C. Paul, P. A. Kaiser, P. A. Pappas, D. M. Meyer, M. A. Wait, M. H. Drazner, et al. Effects of Early Steroid Withdrawal After Heart Transplantation Ann. Thorac. Surg., August 1, 2006; 82(2): 637 - 644. [Abstract] [Full Text] [PDF]

				J. T. Fleenor, T. M. Hoffman, D. M. Bush, S. M. Paridon, B. J. Clark III, T. L. Spray, and N. D. Bridges Pneumatosis Intestinalis After Pediatric Thoracic Organ Transplantation Pediatrics, May 1, 2002; 109(5): e78 - 78. [Abstract] [Full Text] [PDF]

				M. Chiavarelli, M. M. Boucek, S. L. Nehlsen-Cannarella, S. R. Gundry, A. J. Razzouk, L. L. Bailey, and Loma Linda University Pediatric Heart Transplant G Neonatal Cardiac Transplantation: Intermediate-Term Results and Incidence of Rejection Arch Surg, September 1, 1992; 127(9): 1072 - 1076. [Abstract] [PDF]